{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:02:11Z","timestamp":1780621331129,"version":"3.54.1"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Congenital Heart Disease"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijcchd.2026.100661","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:54:26Z","timestamp":1770944066000},"page":"100661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical application of benzathine penicillin G as secondary prophylaxis and vaccines for patients with acute rheumatic fever and rheumatic heart disease: A comprehensive review"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5762-1308","authenticated-orcid":false,"given":"Getinet","family":"Nibret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengistu Abebe","family":"Messelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abebe","family":"Dagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijcchd.2026.100661_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/1573403X13666170116120828","article-title":"Adherence to secondary prophylaxis for acute rheumatic fever and rheumatic heart disease: a systematic review","volume":"13","author":"Kevat","year":"2017","journal-title":"Curr Cardiol Rev"},{"issue":"1","key":"10.1016\/j.ijcchd.2026.100661_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2015.84","article-title":"Acute rheumatic fever and rheumatic heart disease","volume":"2","author":"Carapetis","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ijcchd.2026.100661_bib3","article-title":"Rheumatic heart disease: a review of the current status of global research activity","author":"Dooley","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.ijcchd.2026.100661_bib4","first-page":"140","article-title":"Benzathine penicillin prophylaxis in children with rheumatic fever (RF)\/rheumatic heart disease (RHD): a study of compliance","volume":"3","author":"Tullu","year":"2010","journal-title":"Al Ameen J Med Sci"},{"key":"10.1016\/j.ijcchd.2026.100661_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2147\/CLEP.S12977","article-title":"The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease","volume":"3","author":"Seckeler","year":"2011","journal-title":"Clin Epidemiol"},{"issue":"5","key":"10.1016\/j.ijcchd.2026.100661_bib6","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/ije\/dyy150","article-title":"Primary prevention of rheumatic fever in the 21st century: evaluation of a national programme","volume":"47","author":"Jack","year":"2018","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.ijcchd.2026.100661_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/2395-5414.157554","article-title":"Evolution, evidence and effect of secondary prophylaxis against rheumatic fever","volume":"1","author":"Wyber","year":"2015","journal-title":"J Pract Cardiosvasc Sci"},{"key":"10.1016\/j.ijcchd.2026.100661_bib8","series-title":"Acute rheumatic fever: treatment and prevention","author":"Steer","year":"2020"},{"issue":"9","key":"10.1016\/j.ijcchd.2026.100661_bib9","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJMoa2401802","article-title":"One dose versus three doses of benzathine penicillin G in early syphilis","volume":"393","author":"Hook","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcchd.2026.100661_bib10","article-title":"Acute rheumatic fever and rheumatic heart disease","author":"Sika-Paotonu","year":"2017","journal-title":"Streptococcus Pyogenes: Basic Biol Clin Manifest"},{"issue":"10142","key":"10.1016\/j.ijcchd.2026.100661_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(18)30999-1","article-title":"Acute rheumatic fever","volume":"392","author":"Karthikeyan","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ijcchd.2026.100661_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-017-2747-5","article-title":"Rheumatic heart disease: infectious disease origin, chronic care approach","volume":"17","author":"Katzenellenbogen","year":"2017","journal-title":"BMC Health Serv Res"},{"issue":"10S","key":"10.1016\/j.ijcchd.2026.100661_bib13","doi-asserted-by":"crossref","first-page":"A2019","DOI":"10.1016\/S0735-1097(15)62019-8","article-title":"Adherence to benzathine penicillin in children with rheumatic fever\/rheumatic heart disease: results from an Indian pediatric RHD registry","volume":"65","author":"Saxena","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcchd.2026.100661_bib14","series-title":"Infection and autoimmunity","first-page":"479","article-title":"Rheumatic fever: how streptococcal throat infection triggers an autoimmune disease","author":"Guilherme","year":"2015"},{"issue":"2","key":"10.1016\/j.ijcchd.2026.100661_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11936-017-0513-y","article-title":"Group A streptococcus, acute rheumatic fever and rheumatic heart disease: epidemiology and clinical considerations","volume":"19","author":"Z\u00fchlke","year":"2017","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.ijcchd.2026.100661_bib16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4314\/ahs.v14i3.17","article-title":"Echocardiographic pattern and severity of valve dysfunction in children with rheumatic heart disease seen at Uganda Heart Institute, Mulago hospital","volume":"14","author":"Lubega","year":"2014","journal-title":"Afr Health Sci"},{"issue":"3","key":"10.1016\/j.ijcchd.2026.100661_bib17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/CIRCULATIONAHA.115.020966","article-title":"Long-term outcomes from acute rheumatic fever and rheumatic heart disease: a data-linkage and survival analysis approach","volume":"134","author":"He","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ijcchd.2026.100661_bib18","article-title":"Acute rheumatic fever in Egyptian children: a 30-YearExperience in a tertiary hospital","volume":"6","author":"Elamrousy","year":"2014","journal-title":"J Pediatr Sci"},{"issue":"4","key":"10.1016\/j.ijcchd.2026.100661_bib19","article-title":"Rheumatic fever management and prevention in pediatrics still a challenge","volume":"14","author":"Fida","year":"2007","journal-title":"Med Sci"},{"key":"10.1016\/j.ijcchd.2026.100661_bib20","series-title":"Global status of BPG report, 2016","author":"Wyber","year":"2017"},{"key":"10.1016\/j.ijcchd.2026.100661_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024517","article-title":"Penicillin reactions in patients with severe rheumatic heart disease: a presidential advisory from the American heart association","author":"Sanyahumbi","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"20","key":"10.1016\/j.ijcchd.2026.100661_bib22","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1161\/CIR.0000000000000922","article-title":"The American heart association's call to action for reducing the global burden of rheumatic heart disease: a policy statement from the American heart association","volume":"142","author":"Beaton","year":"2020","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcchd.2026.100661_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3126\/njh.v13i2.15555","article-title":"Comprehensive approach to rheumatic fever and rheumatic heart disease prevention and control: the Nepalese model","volume":"13","author":"Regmi","year":"2016","journal-title":"Nepal Heart J"},{"issue":"2","key":"10.1016\/j.ijcchd.2026.100661_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246519","article-title":"Prevalence of rheumatic heart disease in a major referral cardiology clinic in Ethiopia: a retrospective cross-sectional study","volume":"16","author":"Asmare","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ijcchd.2026.100661_bib25","first-page":"643","article-title":"Rheumatic fever & rheumatic heart disease: the last 50 years","volume":"137","author":"Kumar","year":"2013","journal-title":"Indian J Med Res"},{"issue":"2","key":"10.1016\/j.ijcchd.2026.100661_bib26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.21037\/cdt.2019.10.07","article-title":"Rheumatic heart disease: current status of diagnosis and therapy","volume":"10","author":"Peters","year":"2020","journal-title":"Cardiovasc Diagn Ther"},{"issue":"8","key":"10.1016\/j.ijcchd.2026.100661_bib27","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, regional, and national burden of rheumatic heart disease, 1990\u20132015","volume":"377","author":"Watkins","year":"2017","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ijcchd.2026.100661_bib28","doi-asserted-by":"crossref","first-page":"e717","DOI":"10.1016\/S2214-109X(14)70310-9","article-title":"Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents","volume":"2","author":"Rothenb\u00fchler","year":"2014","journal-title":"Lancet Global Health"},{"issue":"3","key":"10.1016\/j.ijcchd.2026.100661_bib29","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/17441692.2018.1515970","article-title":"Time to tackle rheumatic heart disease: data needed to drive global policy dialogues","volume":"14","author":"Abouzeid","year":"2019","journal-title":"Glob Public Health"},{"key":"10.1016\/j.ijcchd.2026.100661_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2023.108279","article-title":"Cell wall polysaccharides of streptococci: a genetic and structural perspective","author":"Kampff","year":"2023","journal-title":"Biotechnol Adv"},{"issue":"1","key":"10.1016\/j.ijcchd.2026.100661_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.22207\/JPAM.16.1.58","article-title":"Streptococcal pharyngitis and rheumatic fever","volume":"16","author":"Sujhithra","year":"2022","journal-title":"J Pure Appl Microbiol"},{"key":"10.1016\/j.ijcchd.2026.100661_bib32","first-page":"1","article-title":"The microbiome and rheumatic heart disease: current knowledge and future perspectives","author":"Nagarajan","year":"2023","journal-title":"Acta Cardiol"},{"issue":"11","key":"10.1016\/j.ijcchd.2026.100661_bib33","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrcardio.2009.162","article-title":"Prevention and treatment of rheumatic heart disease in the developing world","volume":"6","author":"Steer","year":"2009","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"10.1016\/j.ijcchd.2026.100661_bib34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jama.1944.02850430015005","article-title":"The diagnosis of rheumatic fever","volume":"126","author":"Jones","year":"1944","journal-title":"J Am Med Assoc"},{"issue":"4","key":"10.1016\/j.ijcchd.2026.100661_bib35","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/01.CIR.13.4.617","article-title":"Jones Criteria (modified) for guidance in the diagnosis of rheumatic fever: report of the committee on standards and criteria for programs of care","volume":"13","author":"Rutstein","year":"1956","journal-title":"Circulation"},{"key":"10.1016\/j.ijcchd.2026.100661_bib36","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1001\/jama.1992.03490150121036","volume":"268","author":"Dajani","year":"1992","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.ijcchd.2026.100661_bib37","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/CIR.0000000000000205","article-title":"Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American heart association","volume":"131","author":"Gewitz","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ijcchd.2026.100661_bib38","first-page":"299","article-title":"Evolution of the Jones Criteria for the diagnosis of acute rheumatic fever","author":"Markowitz","year":"1999","journal-title":"Rheumatic Fever Washington: Am Regist Pathol"},{"key":"10.1016\/j.ijcchd.2026.100661_bib39","article-title":"Rheumatic fever and rheumatic heart disease","author":"Organization","year":"2004","journal-title":"Rep WHO Expert Consult Geneva"},{"issue":"5","key":"10.1016\/j.ijcchd.2026.100661_bib40","doi-asserted-by":"crossref","first-page":"220","DOI":"10.5694\/mja2.50851","article-title":"The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease","volume":"214","author":"Ralph","year":"2021","journal-title":"Med J Aust"},{"issue":"6","key":"10.1016\/j.ijcchd.2026.100661_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009399","article-title":"High risk of early sub-therapeutic penicillin concentrations after intramuscular benzathine penicillin G injections in Ethiopian children and adults with rheumatic heart disease","volume":"15","author":"Ketema","year":"2021","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.ijcchd.2026.100661_bib42","article-title":"Secondary antibiotic prophylaxis for latent rheumatic heart disease","author":"Beaton","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ijcchd.2026.100661_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/heartasia-2019-011191","article-title":"Severe adverse events following benzathine penicillin G injection for rheumatic heart disease prophylaxis: cardiac compromise more likely than anaphylaxis","volume":"11","author":"Marantelli","year":"2019","journal-title":"Heart Asia"},{"issue":"2","key":"10.1016\/j.ijcchd.2026.100661_bib44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/1573403X13666170116120828","article-title":"Adherence to secondary prophylaxis for acute rheumatic fever an d rheumatic heart disease: a systematic review","volume":"13","author":"M Kevat","year":"2017","journal-title":"Curr Cardiol Rev"},{"issue":"1457","key":"10.1016\/j.ijcchd.2026.100661_bib45","first-page":"50","article-title":"Adequate adherence to benzathine penicillin secondary prophylaxis following the diagnosis of rheumatic heart disease by echocardiographic screening","volume":"130","author":"Culliford-Semmens","year":"2017","journal-title":"N Z Med J"},{"issue":"3","key":"10.1016\/j.ijcchd.2026.100661_bib46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF02723652","article-title":"Prophylactic efficiency of 3-weekly benzathine penicillin G in rheumatic fever","volume":"67","author":"Oran","year":"2000","journal-title":"Indian J Pediatr"},{"issue":"5","key":"10.1016\/j.ijcchd.2026.100661_bib47","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s13346-016-0313-z","article-title":"Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever","volume":"6","author":"Wyber","year":"2016","journal-title":"Drug Deliv Transl Res"},{"issue":"10S","key":"10.1016\/j.ijcchd.2026.100661_bib48","doi-asserted-by":"crossref","first-page":"E2004","DOI":"10.1016\/S0735-1097(13)62004-5","article-title":"Access to essential medicines: illuminating disparities in the global supply of benzathine penicillin G in the context of rheumatic fever\/rheumatic heart disease prevention","volume":"61","author":"Taubert","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ijcchd.2026.100661_bib49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/0974-2069.197051","article-title":"Rheumatic heart disease screening: current concepts and challenges","volume":"10","author":"Dougherty","year":"2017","journal-title":"Ann Pediatr Cardiol"},{"issue":"10","key":"10.1016\/j.ijcchd.2026.100661_bib50","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1093\/jac\/dkaa282","volume":"75","author":"Kado","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.ijcchd.2026.100661_bib51","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00252-17","article-title":"Penicillin dried blood spot assay for use in patients receiving intramuscular benzathine penicillin G and other penicillin preparations to prevent rheumatic fever","volume":"61","author":"Page-Sharp","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.ijcchd.2026.100661_bib52","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0022-3476(06)80188-5","article-title":"Long-term outcome of patients with rheumatic fever receiving benzathine penicillin G prophylaxis every three weeks versus every four weeks","volume":"125","author":"Lue","year":"1994","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.ijcchd.2026.100661_bib53","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.gheart.2013.08.011","article-title":"Benzathine penicillin G for the management of RHD: concerns about quality and access, and opportunities for intervention and improvement","volume":"8","author":"Wyber","year":"2013","journal-title":"Global heart"},{"key":"10.1016\/j.ijcchd.2026.100661_bib54","series-title":"Acute rheumatic fever and rheumatic heart disease","first-page":"207","article-title":"Secondary prevention of acute rheumatic fever and rheumatic heart disease","author":"de Dassel","year":"2021"},{"key":"10.1016\/j.ijcchd.2026.100661_bib55","series-title":"Rheumatic heart disease prophylaxis in older patients: a register-based audit of adherence to guidelines. Open forum infectious diseases","year":"2018"},{"issue":"6","key":"10.1016\/j.ijcchd.2026.100661_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.668","article-title":"Quality of benzathine penicillin G: a multinational cross\u2010sectional study","volume":"8","author":"Hand","year":"2020","journal-title":"Pharmacology research & perspectives"},{"issue":"6","key":"10.1016\/j.ijcchd.2026.100661_bib57","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/1753-6405.12415","article-title":"Supply of benzathine penicillin G: the 20-year experience in Australia","volume":"39","author":"Wyber","year":"2015","journal-title":"Aust NZJ Public Health"},{"issue":"5","key":"10.1016\/j.ijcchd.2026.100661_bib59","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1128\/AAC.38.5.1203","article-title":"Penicillin concentrations after increased doses of benzathine penicillin G for prevention of secondary rheumatic fever","volume":"38","author":"Currie","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.ijcchd.2026.100661_bib60","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1093\/jac\/dkz076","article-title":"A population pharmacokinetic study of benzathine benzylpenicillin G administration in children and adolescents with rheumatic heart disease: new insights for improved secondary prophylaxis strategies","volume":"74","author":"Hand","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.ijcchd.2026.100661_bib61","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1128\/AAC.02744-14","article-title":"A population pharmacokinetic modeling approach shows that serum penicillin G concentrations are below inhibitory concentrations by two weeks after benzathine penicillin G injection in the majority of young adults","volume":"58","author":"Neely","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.ijcchd.2026.100661_bib62","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ihj.2020.11.151","article-title":"Out-of-pocket expenditure for administration of benzathine penicillin G injections for secondary prophylaxis in patients with rheumatic heart disease: a registry-based data from a tertiary care center in Northern India","volume":"73","author":"Arvind","year":"2021","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ijcchd.2026.100661_bib63","series-title":"Factors, beliefs and barriers associated with adherence to secondary prophylaxis amongst children and adolescents with rheumatic heart disease at public tertiary hospitals in Rwanda\u2013a cross-sectional study","author":"Janvier","year":"2019"},{"key":"10.1016\/j.ijcchd.2026.100661_bib64","series-title":"International drug monitoring: the role of the hospital, report of a WHO meeting [held in Geneva from 18 to 23 November 1968]","author":"Organization","year":"1969"},{"key":"10.1016\/j.ijcchd.2026.100661_bib65","series-title":"Global status of BPG report","author":"Wyber","year":"2016"},{"issue":"1","key":"10.1016\/j.ijcchd.2026.100661_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-015-1303-3","article-title":"The prevalence and impact of antimicrobial allergies and adverse drug reactions at an Australian tertiary centre","volume":"15","author":"Trubiano","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.ijcchd.2026.100661_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056463","article-title":"Safety of benzathine penicillin for preventing congenital syphilis: a systematic review","volume":"8","author":"Galvao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcchd.2026.100661_bib68","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0099-5428(08)60421-9","article-title":"Penicillin G, potassium (potassium benzylpenicillin)","volume":"15","author":"Kirschbaum","year":"1986","journal-title":"Anal Profiles Drug Subst"},{"issue":"1","key":"10.1016\/j.ijcchd.2026.100661_bib69","first-page":"41","article-title":"Nicolau syndrome following intramuscular penicillin injection","volume":"22","author":"Karimi","year":"2012","journal-title":"J Coll Physician Surg Pak"},{"issue":"8","key":"10.1016\/j.ijcchd.2026.100661_bib70","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/01.inf.0000226941.85500.9b","article-title":"Nicolau syndrome after intramuscular benzathine penicillin treatment","volume":"25","author":"Ocak","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijcchd.2026.100661_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.760255","article-title":"Antibiotic treatment, mechanisms for failure, and adjunctive therapies for infections by group A streptococcus","volume":"12","author":"Johnson","year":"2021","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.ijcchd.2026.100661_bib72","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.201991","article-title":"A brief review on group A streptococcus pathogenesis and vaccine development","volume":"8","author":"Castro","year":"2021","journal-title":"R Soc Open Sci"},{"key":"10.1016\/j.ijcchd.2026.100661_bib73","series-title":"Quantitative and structural insights into the streptococcal Antigen-ome","author":"Chowdhury","year":"2022"},{"issue":"1","key":"10.1016\/j.ijcchd.2026.100661_bib74","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/geriatrics6010013","article-title":"Pneumococcal pneumonia and invasive pneumococcal disease in those 65 and older: rates of detection, risk factors, vaccine effectiveness, hospitalisation and mortality","volume":"6","author":"Thomas","year":"2021","journal-title":"Geriatrics"},{"issue":"12","key":"10.1016\/j.ijcchd.2026.100661_bib75","article-title":"Group A streptococcus infections: their mechanisms, epidemiology, and current scope of vaccines","volume":"14","author":"Iyer","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.ijcchd.2026.100661_bib76","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41541-023-00609-x","article-title":"The Streptococcus pyogenes vaccine landscape","volume":"8","author":"Walkinshaw","year":"2023","journal-title":"npj Vaccines"},{"issue":"12","key":"10.1016\/j.ijcchd.2026.100661_bib77","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.vaccine.2013.01.019","article-title":"Potential coverage of a multivalent M protein-based group A streptococcal vaccine","volume":"31","author":"Dale","year":"2013","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.ijcchd.2026.100661_bib78","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41588-019-0417-8","article-title":"Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics","volume":"51","author":"Davies","year":"2019","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.ijcchd.2026.100661_bib79","doi-asserted-by":"crossref","first-page":"44","DOI":"10.21276\/aimdr.2019.5.3.ME12","article-title":"Developing a vaccine for rheumatic fever and rheumatic heart disease: a review of current research strategies and challenges","volume":"5","author":"Chowdhury","year":"2019","journal-title":"Ann Int Med Dent Res"},{"issue":"7","key":"10.1016\/j.ijcchd.2026.100661_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198658","article-title":"Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial","volume":"13","author":"Sekuloski","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijcchd.2026.100661_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14157-7","article-title":"Physicochemical characterisation, immunogenicity and protective efficacy of a lead streptococcal vaccine: progress towards Phase I trial","volume":"7","author":"Pandey","year":"2017","journal-title":"Sci Rep"},{"issue":"16","key":"10.1016\/j.ijcchd.2026.100661_bib82","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/j.vaccine.2017.02.060","article-title":"Clinical development strategy for a candidate group A streptococcal vaccine","volume":"35","author":"Sch\u00f6del","year":"2017","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ijcchd.2026.100661_bib83","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1128\/IAI.71.3.1361-1369.2003","article-title":"Two novel superantigens found in both group A and group C streptococcus","volume":"71","author":"Proft","year":"2003","journal-title":"Infect Immun"}],"container-title":["International Journal of Cardiology Congenital Heart Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666668526000108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666668526000108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:19:14Z","timestamp":1780618754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666668526000108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":82,"alternative-id":["S2666668526000108"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcchd.2026.100661","relation":{},"ISSN":["2666-6685"],"issn-type":[{"value":"2666-6685","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical application of benzathine penicillin G as secondary prophylaxis and vaccines for patients with acute rheumatic fever and rheumatic heart disease: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Congenital Heart Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcchd.2026.100661","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100661"}}